FTC Continues Crackdown On CBD Sellers’ Cure-All Claims



Law360 (May 17, 2021, 3:31 PM EDT) — The Federal Trade Commission said Monday that Arizona-based CBD company Kushly and its owner will pay $30,000 in consumer redress after an investigation revealed their deceptive marketing practices and unsubstantiated claims that CBD products could help treat Parkinson’s disease, Alzheimer’s disease, cancer, multiple sclerosis, hypertension and other serious ailments.

Kushly Industries LLC and its owner Cody Alt agreed to pay the FTC more than $30,000 in consumer redress and to not falsely claim to consumers that any of its cannabidiol, or CBD, products are clinically proven to treat, alleviate or cure either serious medical conditions or more common afflictions such as…

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS



Source link

You May Also Like